EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes
Status:
Completed
Trial end date:
2019-02-25
Target enrollment:
Participant gender:
Summary
The objectives of this study is to:
- Evaluate the tolerability of a combination therapy with Diamyd, vitamin D and etanercept
- Evaluate how the above mentioned treatments influence the immune system and endogenous
insulin secretion
Phase:
Phase 2
Details
Lead Sponsor:
Johnny Ludvigsson
Collaborators:
Diamyd Medical AB Ostergotland County Council, Sweden Sahlgrenska University Hospital, Sweden Swedish Child Diabetes Foundation
Treatments:
Cholecalciferol Ergocalciferols Etanercept Vitamin D Vitamins